Skip to main content
Top
Published in: Journal of Cancer Education 1/2011

01-03-2011

Do Recently Diagnosed Black Breast Cancer Patients Find Questions About Cancer Fatalism Acceptable? A Preliminary Report

Authors: Vanessa B. Sheppard, Kimberly Davis, Mare Boisvert, Yvonne Jennings, Becky Montalvo

Published in: Journal of Cancer Education | Issue 1/2011

Login to get access

Abstract

Socio-cultural factors such as cancer fatalism have been understudied in cancer patients. Women from two cancer centers completed a structured phone survey and an open-ended cognitive interview. Socio-cultural variables of fatalism, hope, and spiritual coping were measured using standardized scales. Older women had significantly higher fatalism scores compared to younger women (p < 0.01). Fatalism rates were low. Ratings of hope and collaborative religious coping were high (m = 20, m = 35, respectively). Qualitative comments confirmed the overall low acceptability of the fatalism measures. Further research is needed to identify measures that are acceptable to newly diagnosed patients.
Literature
1.
go back to reference Djuric Z, DiLaura NM, Jenkins I et al (2002) Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res 10:657–665CrossRefPubMed Djuric Z, DiLaura NM, Jenkins I et al (2002) Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res 10:657–665CrossRefPubMed
2.
go back to reference Williams KP, Mullan PB, Todem D (2009) Moving from theory to practice: implementing the Kin Keeper Cancer Prevention Model. Health Educ Res 24:343–356CrossRefPubMed Williams KP, Mullan PB, Todem D (2009) Moving from theory to practice: implementing the Kin Keeper Cancer Prevention Model. Health Educ Res 24:343–356CrossRefPubMed
3.
go back to reference Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490–496PubMed Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:490–496PubMed
5.
go back to reference Phillips JM, Cohen MZ, Tarzian AJ (2001) African American women's experiences with breast cancer screening. J Nurs Scholarsh 33:135–140CrossRefPubMed Phillips JM, Cohen MZ, Tarzian AJ (2001) African American women's experiences with breast cancer screening. J Nurs Scholarsh 33:135–140CrossRefPubMed
6.
go back to reference Bickell NA, Wang JJ, Oluwole S et al (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24:1357–1362CrossRefPubMed Bickell NA, Wang JJ, Oluwole S et al (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24:1357–1362CrossRefPubMed
7.
go back to reference Ell K, Padgett D, Vourlekis B et al (2002) Abnormal mammogram follow-up: a pilot study women with low income. Cancer Pract 10:130–138CrossRefPubMed Ell K, Padgett D, Vourlekis B et al (2002) Abnormal mammogram follow-up: a pilot study women with low income. Cancer Pract 10:130–138CrossRefPubMed
8.
go back to reference Guidry JJ, Matthews-Juarez P, Copeland VA (2003) Barriers to breast cancer control for African-American women: the interdependence of culture and psychosocial issues. Cancer 97:318–323CrossRefPubMed Guidry JJ, Matthews-Juarez P, Copeland VA (2003) Barriers to breast cancer control for African-American women: the interdependence of culture and psychosocial issues. Cancer 97:318–323CrossRefPubMed
9.
go back to reference Maliski SL, Clerkin B, Litwin MS (2004) Describing a nurse case manager intervention to empower low-income men with prostate cancer. Oncol Nurs Forum 31:57–64CrossRefPubMed Maliski SL, Clerkin B, Litwin MS (2004) Describing a nurse case manager intervention to empower low-income men with prostate cancer. Oncol Nurs Forum 31:57–64CrossRefPubMed
10.
go back to reference Mandelblatt JS, Gold K, O'Malley AS et al (1999) Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med 28:418–425CrossRefPubMed Mandelblatt JS, Gold K, O'Malley AS et al (1999) Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med 28:418–425CrossRefPubMed
11.
go back to reference Mayo RM, Ureda JR, Parker VG (2001) Importance of fatalism in understanding mammography screening in rural elderly women. J Women Aging 13:57–72CrossRefPubMed Mayo RM, Ureda JR, Parker VG (2001) Importance of fatalism in understanding mammography screening in rural elderly women. J Women Aging 13:57–72CrossRefPubMed
12.
go back to reference Peek ME (2007) An innovative partnership to address breast cancer screening among vulnerable populations. Educ Health (Abingdon) 20:52 Peek ME (2007) An innovative partnership to address breast cancer screening among vulnerable populations. Educ Health (Abingdon) 20:52
13.
14.
go back to reference Magai C, Consedine NS, Adjei BA et al (2008) Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention. Health Educ Behav 35:835–854CrossRefPubMed Magai C, Consedine NS, Adjei BA et al (2008) Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention. Health Educ Behav 35:835–854CrossRefPubMed
15.
go back to reference Mandelblatt JS, Schechter CB, Yabroff KR et al (2004) Benefits and costs of interventions to improve breast cancer outcomes in African American women. J Clin Oncol 22:2554–2566CrossRefPubMed Mandelblatt JS, Schechter CB, Yabroff KR et al (2004) Benefits and costs of interventions to improve breast cancer outcomes in African American women. J Clin Oncol 22:2554–2566CrossRefPubMed
16.
go back to reference Sheppard VB, Williams KP, Harrison TM et al (2010) Development of decision-support intervention for Black women with breast cancer. Psychooncology 19:62–70CrossRefPubMed Sheppard VB, Williams KP, Harrison TM et al (2010) Development of decision-support intervention for Black women with breast cancer. Psychooncology 19:62–70CrossRefPubMed
17.
go back to reference Gullatte MM, Brawley O, Kinney A et al (2010) Religiosity, spirituality, and cancer fatalism beliefs on delay in breast cancer diagnosis in African American women. J Relig Health 49:62–72CrossRefPubMed Gullatte MM, Brawley O, Kinney A et al (2010) Religiosity, spirituality, and cancer fatalism beliefs on delay in breast cancer diagnosis in African American women. J Relig Health 49:62–72CrossRefPubMed
19.
go back to reference Powe BD (1995) Cancer fatalism among elderly Caucasians and African Americans. Oncol Nurs Forum 22:1355–1359PubMed Powe BD (1995) Cancer fatalism among elderly Caucasians and African Americans. Oncol Nurs Forum 22:1355–1359PubMed
20.
go back to reference Herth K (1992) Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs 17:1251–1259CrossRefPubMed Herth K (1992) Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs 17:1251–1259CrossRefPubMed
21.
go back to reference Johnson RL, Saha S, Arbelaez JJ et al (2004) Racial and ethnic differences in patient perceptions of bias and cultural competence in health care. J Gen Intern Med 19:101–110CrossRefPubMed Johnson RL, Saha S, Arbelaez JJ et al (2004) Racial and ethnic differences in patient perceptions of bias and cultural competence in health care. J Gen Intern Med 19:101–110CrossRefPubMed
22.
go back to reference Bird ST, Bogart LM (2001) Perceived race-based and socioeconomic status (SES)-based discrimination in interactions with health care providers. Ethn Dis 11:554–563PubMed Bird ST, Bogart LM (2001) Perceived race-based and socioeconomic status (SES)-based discrimination in interactions with health care providers. Ethn Dis 11:554–563PubMed
23.
go back to reference Hughes C, Fasaye GA, LaSalle VH et al (2003) Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 51:107–114CrossRefPubMed Hughes C, Fasaye GA, LaSalle VH et al (2003) Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 51:107–114CrossRefPubMed
24.
go back to reference Katz JN, Chang LC, Sangha O et al (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73–84CrossRefPubMed Katz JN, Chang LC, Sangha O et al (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73–84CrossRefPubMed
25.
go back to reference Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448CrossRefPubMed Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448CrossRefPubMed
26.
go back to reference Gibson LM, Parker V (2003) Inner resources as predictors of psychological well-being in middle-income African American breast cancer survivors. Cancer Control 10:52–59PubMed Gibson LM, Parker V (2003) Inner resources as predictors of psychological well-being in middle-income African American breast cancer survivors. Cancer Control 10:52–59PubMed
27.
go back to reference Matsuyama RK, Grange C, Lyckholm LJ et al (2007) Cultural perceptions in cancer care among African-American and Caucasian patients. J Natl Med Assoc 99:1113–1118PubMed Matsuyama RK, Grange C, Lyckholm LJ et al (2007) Cultural perceptions in cancer care among African-American and Caucasian patients. J Natl Med Assoc 99:1113–1118PubMed
28.
go back to reference Conrad ME, Brown P, Conrad MG (1996) Fatalism and breast cancer in black women. Ann Intern Med 125:941–942PubMed Conrad ME, Brown P, Conrad MG (1996) Fatalism and breast cancer in black women. Ann Intern Med 125:941–942PubMed
29.
go back to reference Mohamed IE, Skeel WK, Tamburrino M et al (2005) Understanding locally advanced breast cancer: what influences a woman's decision to delay treatment? Prev Med 41:399–405CrossRefPubMed Mohamed IE, Skeel WK, Tamburrino M et al (2005) Understanding locally advanced breast cancer: what influences a woman's decision to delay treatment? Prev Med 41:399–405CrossRefPubMed
30.
go back to reference Phillips JM, Cohen MZ, Moses G (1999) Breast cancer screening and African American women: fear, fatalism, and silence. Oncol Nurs Forum 26:561–571PubMed Phillips JM, Cohen MZ, Moses G (1999) Breast cancer screening and African American women: fear, fatalism, and silence. Oncol Nurs Forum 26:561–571PubMed
31.
go back to reference Powe BD, Weinrich S (1999) An intervention to decrease cancer fatalism among rural elders. Oncol Nurs Forum 26:583–588PubMed Powe BD, Weinrich S (1999) An intervention to decrease cancer fatalism among rural elders. Oncol Nurs Forum 26:583–588PubMed
32.
go back to reference Powe BD, Daniels EC, Finnie R (2005) Comparing perceptions of cancer fatalism among African American patients and their providers. J Am Acad Nurse Pract 17:318–324CrossRefPubMed Powe BD, Daniels EC, Finnie R (2005) Comparing perceptions of cancer fatalism among African American patients and their providers. J Am Acad Nurse Pract 17:318–324CrossRefPubMed
Metadata
Title
Do Recently Diagnosed Black Breast Cancer Patients Find Questions About Cancer Fatalism Acceptable? A Preliminary Report
Authors
Vanessa B. Sheppard
Kimberly Davis
Mare Boisvert
Yvonne Jennings
Becky Montalvo
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 1/2011
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-010-0134-6

Other articles of this Issue 1/2011

Journal of Cancer Education 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine